CME Group Inc. (NASDAQ:CME) CFO John W. Pietrowicz sold 5,175 shares of the stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $139.70, for a total value of $722,947.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Shares of CME Group Inc. (NASDAQ CME) opened at $140.15 on Tuesday. The company has a market capitalization of $46,757.18, a PE ratio of 28.84, a P/E/G ratio of 2.82 and a beta of 0.71. CME Group Inc. has a 52-week low of $111.19 and a 52-week high of $141.07. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.05 and a current ratio of 1.05.
CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. The firm had revenue of $890.80 million during the quarter, compared to analysts’ expectations of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.05 EPS. analysts expect that CME Group Inc. will post 4.8 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 1.88%. The ex-dividend date is Thursday, December 7th. CME Group’s dividend payout ratio is presently 59.86%.
WARNING: This report was reported by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.truebluetribune.com/2017/11/14/john-w-pietrowicz-sells-5175-shares-of-cme-group-inc-cme-stock.html.
A number of equities research analysts have commented on CME shares. Wells Fargo & Company raised their target price on CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a report on Wednesday, October 4th. Royal Bank Of Canada raised their target price on CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a report on Monday, October 16th. Jefferies Group LLC reissued a “buy” rating and issued a $134.00 target price (up previously from $128.00) on shares of CME Group in a report on Monday, July 17th. Barclays PLC started coverage on CME Group in a report on Friday, September 8th. They issued an “overweight” rating and a $139.00 target price for the company. Finally, BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, September 13th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $138.89.
A number of institutional investors have recently bought and sold shares of CME. Carret Asset Management LLC purchased a new stake in CME Group in the 3rd quarter valued at about $207,000. First Republic Investment Management Inc. grew its holdings in CME Group by 2.3% in the 3rd quarter. First Republic Investment Management Inc. now owns 35,251 shares of the financial services provider’s stock valued at $4,783,000 after buying an additional 787 shares during the period. Jackson Square Partners LLC purchased a new stake in CME Group in the 3rd quarter valued at about $48,724,000. AMP Capital Investors Ltd grew its holdings in CME Group by 8.0% in the 3rd quarter. AMP Capital Investors Ltd now owns 232,975 shares of the financial services provider’s stock valued at $31,609,000 after buying an additional 17,247 shares during the period. Finally, Lido Advisors LLC purchased a new stake in CME Group in the 3rd quarter valued at about $590,000. Hedge funds and other institutional investors own 82.63% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.